Dr Holger Laux | Fellow
Novartis Pharma

Dr Holger Laux, Fellow, Novartis Pharma

Dr. Laux is leading the mammalian expression platform of Technical Development NBE unit, Novartis Basel. Throughout his career he focused his work on functional genomics approaches as transcriptomics screens and subsequently cell line engineering editing. These efforts resulted in generation of several improved CHO production cell lines. He was also supporting the sequencing of Chinese hamster resulting in a public available Chinese hamster genome. He is additionally involved in enabling and improving the production of difficult to express therapeutic recombinant proteins

back to speakers